Company / Total Assets
Biogen Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$29.4B
FY2025
5-year range
$23.9B / $29.4B
FY2021-FY2025
Trend
+5.0%
vs FY2024
Sector context
#13 of 216
Health Care
What the data says
Among 216 Health Care companies, Biogen is in the top 6% for total assets. Total Assets has increased for 4 consecutive years, from $23.9B in FY2021 to $29.4B in FY2025.
Based on SEC 10-K filings.
$29.4B in FY2025 with a 5-year CAGR of +3.6%. Top quartile in the Health Care sector.
Improved from $26.8B to $29.4B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +6.2%
- 5-Year CAGR
- +3.6%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 216This company $29.4B Sector average $7.4B
▼
+295.2% above sector average
Key checks
Key Insights
- Biogen's total assets has grown for 4 consecutive years.
- 5-year CAGR of +3.6%, indicating consistent growth.
- In FY2025, total assets increased 5.0% year-over-year.
- Ranks #13 out of 216 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.4B | +5.0% |
| FY2024 | $28.0B | +4.5% |
| FY2023 | $26.8B | +9.3% |
| FY2022 | $24.6B | +2.8% |
| FY2021 | $23.9B | -3.0% |
| FY2020 | $24.6B | -9.6% |
| FY2019 | $27.2B | +7.7% |
| FY2018 | $25.3B | +6.9% |
| FY2017 | $23.7B | +3.4% |
| FY2016 | $22.9B | +17.3% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026